Pricing and Reimbursement Challenges in the Netherlands
heor.tv ask Marjolein Pompen what the current pricing and reimbursement activities she is doing now as opposed to previously in order to keep drugs in the Dutch market.
heor.tv ask Marjolein Pompen what the current pricing and reimbursement activities she is doing now as opposed to previously in order to keep drugs in the Dutch market.
The future of medical publishing might be e-publishing. Will there be a role for print journals?
The UK National Institute for Health and Clinical Excellence (NICE) has overhauled its technology appeals process with the aim of making it quicker and slicker. Despite the efforts at greater clarity, the short period for appealing final decisions remains, so time is of the essence.
Structural intervention may be what’s needed to tackle chronic health problems. But big ideas prompt big questions, including: How much will this cost? Who will pay for it? And how do we get ‘buy-in’?
Obesity, and its evil cousins diabetes and heart disease, are not going to be cured by more doctor visits. It’s going to take a complete remake of our environment.